Bright Minds Biosciences (DRUG) Net Income towards Common Stockholders (2019 - 2026)
Bright Minds Biosciences (DRUG) recorded Net Income towards Common Stockholders of -$1.73 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $3.78 million a year earlier.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
On a TTM basis, Bright Minds Biosciences' Net Income towards Common Stockholders came in at $4.14 million as of Jun 30, 2026, up 0.7% year-over-year; for FY2025 (ended Sep 30, 2025), it was -$8.75 million.
- Across earlier fiscal years, Net Income towards Common Stockholders came in at -$2.06 million in FY2024, $1.06 million in FY2023, -$11.72 trillion in FY2022 and -$6.84 trillion in FY2021.
- Quarterly Net Income towards Common Stockholders has ranged from -$6.87 trillion in fiscal Q4 2021 to $20.77 million in fiscal Q2 2026 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at $20.77 million (Q2 2026), -$6.01 million (Q1 2026) and -$8.89 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Bright Minds Biosciences | 387.06 Mn | 387.06 Mn | - | -1.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.73 Mn |
| Mar 31, 2026 | 20.77 Mn |
| Dec 31, 2025 | -6.01 Mn |
| Sep 30, 2025 | -8.89 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 32,422.24 |
| Sep 30, 2024 | -2.05 Mn |
| Jun 30, 2024 | 302,577.40 |
| Mar 31, 2024 | -426,077.62 |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | -1.09 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.72 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | -3.54 Mn |
| Dec 31, 2021 | 3.85 Mn |
| Sep 30, 2021 | -6,872.25 Bn |
API Access
Bright Minds Biosciences Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();